Ashkan M Abbey

Ashkan M Abbey

Harvard University - Cambridge / United States
Others
AD Scientific Index ID: 1565419
person_outline Ashkan M Abbey's MOST POPULAR ARTICLES
1-) Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...The Lancet 399 (10326), 741-755, 20221062022
2-) Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double …JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ...The Lancet 399 (10326), 729-740, 20221362022
3-) Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham …JS Heier, EM Lad, FG Holz, PJ Rosenfeld, RH Guymer, D Boyer, F Grossi, ...The Lancet 402 (10411), 1434-1448, 20231242023
4-) Sutureless scleral fixation of intraocular lenses: outcomes of two approaches. The 2014 Yasuo Tano Memorial LectureAM Abbey, RM Hussain, AR Shah, LJ Faia, JD Wolfe, GA WilliamsGraefe\'s Archive for Clinical and Experimental Ophthalmology 253, 1-5, 20151202015
5-) Femtosecond laser-assisted astigmatic keratotomy in naturally occurring high astigmatismA Abbey, T Ide, GD Kymionis, SH YooBritish journal of ophthalmology 93 (12), 1566-1569, 20091172009